
ALT New analysis by Public Health England (PHE) shows for the first time that two doses of the COVID-19 vaccines are highly effective against hospitalisation from the Delta (B.1.61.2) variant. The analysis suggests: • The Pfizer-BioNTech vaccine is 96% effective against hospitalisation after 2 doses. • The Oxford-AstraZeneca vaccine is 92% effective against hospitalisation after 2 doses. These are comparable with vaccine effectiveness against hospitalisation from the Alpha variant.

ALT Strategic Incident Director for COVID-19, Professor Keith Willett: ‘I’m honoured to be offered this recognition. I am also acutely aware of the very many good people in the NHS family who in recent times have given so much, and some, everything and would like to put on record my gratitude to everyone in the NHS for their work in the past year.’



















